NO930710D0 - Pro-legemidler for cck-antagonister - Google Patents

Pro-legemidler for cck-antagonister

Info

Publication number: NO930710D0
Authority: NO; Norway
Prior art keywords: pro; drugs; agents; useful; treatment
Prior art date: 1990-08-31

Application number

NO1993930710A

Other languages

English (en)

Other versions

NO300324B1 (no

NO930710L (no

Inventor

David Christopher Horwell

Martyn Clive Pritchard

Reginald Stewart Richardson

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-08-31

Filing date

1993-02-26

Publication date

1993-02-26

1991-07-12 Priority claimed from US07/726,653 external-priority patent/US5340825A/en

1993-02-26 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

1993-02-26 Publication of NO930710D0 publication Critical patent/NO930710D0/no

1993-04-21 Publication of NO930710L publication Critical patent/NO930710L/no

1997-05-12 Publication of NO300324B1 publication Critical patent/NO300324B1/no

Links

229940002612 prodrug Drugs 0.000 title abstract 5
239000000651 prodrug Substances 0.000 title abstract 5
239000005557 antagonist Substances 0.000 title 1
RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 abstract 2
239000003795 chemical substances by application Substances 0.000 abstract 2
ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 abstract 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
102100021022 Gastrin Human genes 0.000 abstract 1
108010052343 Gastrins Proteins 0.000 abstract 1
LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
208000008589 Obesity Diseases 0.000 abstract 1
206010033664 Panic attack Diseases 0.000 abstract 1
IMMPMHKLUUZKAZ-WMZOPIPTSA-N Trp-Phe Chemical class C([C@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)N)C(O)=O)C1=CC=CC=C1 IMMPMHKLUUZKAZ-WMZOPIPTSA-N 0.000 abstract 1
239000000164 antipsychotic agent Substances 0.000 abstract 1
229940005529 antipsychotics Drugs 0.000 abstract 1
239000003699 antiulcer agent Substances 0.000 abstract 1
239000002249 anxiolytic agent Substances 0.000 abstract 1
229960001948 caffeine Drugs 0.000 abstract 1
VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 abstract 1
AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 abstract 1
230000001684 chronic effect Effects 0.000 abstract 1
229960003920 cocaine Drugs 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
230000001419 dependent effect Effects 0.000 abstract 1
AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 abstract 1
229960003529 diazepam Drugs 0.000 abstract 1
210000004211 gastric acid Anatomy 0.000 abstract 1
239000000543 intermediate Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
229960002715 nicotine Drugs 0.000 abstract 1
SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 abstract 1
235000020824 obesity Nutrition 0.000 abstract 1
229940005483 opioid analgesics Drugs 0.000 abstract 1
208000019906 panic disease Diseases 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Crystallography & Structural Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Obesity (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Diabetes (AREA)
Child & Adolescent Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO930710A 1990-08-31 1993-02-26 Analogifremgangsmåte til fremstilling av terapeutisk aktive forbindelser NO300324B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US57631590A	1990-08-31	1990-08-31
US07/726,653 US5340825A (en)	1990-08-31	1991-07-12	Pro drugs for CCK antagonists
PCT/US1991/006178 WO1992004038A1 (en)	1990-08-31	1991-08-29	Pro-drugs for cck antagonists

Publications (3)

Publication Number	Publication Date
NO930710D0 true NO930710D0 (no)	1993-02-26
NO930710L NO930710L (no)	1993-04-21
NO300324B1 NO300324B1 (no)	1997-05-12

Family

ID=27076930

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO930710A NO300324B1 (no)	1990-08-31	1993-02-26	Analogifremgangsmåte til fremstilling av terapeutisk aktive forbindelser

Country Status (14)

Country	Link
US (2)	US5554643A (no)
EP (1)	EP0546108B1 (no)
JP (1)	JP3356431B2 (no)
AT (1)	ATE208400T1 (no)
AU (1)	AU649077B2 (no)
CA (1)	CA2088980C (no)
DE (1)	DE69132805T2 (no)
DK (1)	DK0546108T3 (no)
ES (1)	ES2167312T3 (no)
IE (1)	IE913079A1 (no)
NO (1)	NO300324B1 (no)
NZ (1)	NZ239591A (no)
PT (1)	PT98831B (no)
WO (1)	WO1992004038A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2167312T3 (es) *	1990-08-31	2002-05-16	Warner Lambert Co	Profarmacos para antagonistas de la colecistoquinina.
CZ282536B6 (cs) *	1991-07-12	1997-08-13	Warner-Lambert Company	Nepřirozený dipeptoid pro výrobu léčiva pro prevenci a léčbu záchvatů panického strachu
US5217957A (en) *	1991-08-20	1993-06-08	Warner-Lambert Company	Cholecystokinin antagonists useful for treating depression
US5380872A (en) *	1992-07-14	1995-01-10	Glaxo Inc.	Modulators of cholecystokinin
EP1000930A3 (en) *	1992-08-13	2003-10-29	Warner-Lambert Company	Tachykinin antagonists
TW281669B (no) *	1993-02-17	1996-07-21	Chugai Pharmaceutical Co Ltd
US6869957B1 (en)	1993-11-17	2005-03-22	Eli Lilly And Company	Non-peptide tachykinin receptor antagonists
US6403577B1 (en) *	1993-11-17	2002-06-11	Eli Lilly And Company	Hexamethyleneiminyl tachykinin receptor antagonists
US7077822B1 (en)	1994-02-09	2006-07-18	The University Of Iowa Research Foundation	Stereotactic hypothalamic obesity probe
US6129685A (en) *	1994-02-09	2000-10-10	The University Of Iowa Research Foundation	Stereotactic hypothalamic obesity probe
CA2152765A1 (en)	1994-06-30	1995-12-31	Jeroen Elisabeth-Joseph Knops	Methods for treating a physiological disorder associated with beta amyloid peptide
US7109326B2 (en) *	1997-04-15	2006-09-19	Genentech, Inc.	Halo-alkoxycarbonyl prodrugs
WO2008031221A1 (en)	2006-09-12	2008-03-20	Cephalin Pharmaceuticals Inc.	Isovaline for treatment of pain
JP7509340B2 (ja) *	2016-03-14	2024-07-02	ピボットホールディングスエルエルシー	トリゴネリンベースの化合物
US20200109117A1 (en) *	2018-10-02	2020-04-09	ACCESS Association	Modified Therapeutic Agent Analogs of Mefenamic Acid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2364659A1 (fr) *	1976-09-21	1978-04-14	Commissariat Energie Atomique	Medicament antagoniste de l'action de la gastrine et des polypeptides apparentes
US4757151A (en) *	1985-11-14	1988-07-12	Warner-Lambert Company	2-substituted-[2-substituted-amino]-N-arylalkyl-3-[indol-3-yl]
EP0336356A3 (en) *	1988-04-05	1991-09-25	Abbott Laboratories	Derivatives of tryptophan as cck antagonists
US4997950A (en) *	1989-04-20	1991-03-05	Richard Finbar Murphy	Novel C-terminal gastrin antagonists
US5278316A (en) *	1989-06-29	1994-01-11	Warner-Lambert Company	N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp-Phe- and phenethylamine derivatives
NZ234264A (en) *	1989-06-29	1993-05-26	Warner Lambert Co	N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives, and pharmaceutical compositions
ES2167312T3 (es) *	1990-08-31	2002-05-16	Warner Lambert Co	Profarmacos para antagonistas de la colecistoquinina.

1991
- 1991-08-29 ES ES91918120T patent/ES2167312T3/es not_active Expired - Lifetime
- 1991-08-29 JP JP51666591A patent/JP3356431B2/ja not_active Expired - Fee Related
- 1991-08-29 EP EP91918120A patent/EP0546108B1/en not_active Expired - Lifetime
- 1991-08-29 NZ NZ23959191A patent/NZ239591A/en unknown
- 1991-08-29 AT AT91918120T patent/ATE208400T1/de not_active IP Right Cessation
- 1991-08-29 DK DK91918120T patent/DK0546108T3/da active
- 1991-08-29 WO PCT/US1991/006178 patent/WO1992004038A1/en active IP Right Grant
- 1991-08-29 DE DE69132805T patent/DE69132805T2/de not_active Expired - Fee Related
- 1991-08-29 CA CA002088980A patent/CA2088980C/en not_active Expired - Fee Related
- 1991-08-29 AU AU87250/91A patent/AU649077B2/en not_active Ceased
- 1991-08-30 PT PT98831A patent/PT98831B/pt not_active IP Right Cessation
- 1991-08-30 IE IE307991A patent/IE913079A1/en not_active Application Discontinuation
1993
- 1993-02-26 NO NO930710A patent/NO300324B1/no not_active IP Right Cessation
1994
- 1994-04-13 US US08/227,211 patent/US5554643A/en not_active Expired - Fee Related
1996
- 1996-06-10 US US08/661,254 patent/US5726200A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DK0546108T3 (da)	2002-02-18
CA2088980C (en)	2002-04-16
EP0546108A4 (en)	1993-09-22
JPH06501007A (ja)	1994-01-27
NO300324B1 (no)	1997-05-12
IE913079A1 (en)	1992-03-11
JP3356431B2 (ja)	2002-12-16
EP0546108B1 (en)	2001-11-07
US5726200A (en)	1998-03-10
ES2167312T3 (es)	2002-05-16
PT98831A (pt)	1992-08-31
WO1992004038A1 (en)	1992-03-19
US5554643A (en)	1996-09-10
ATE208400T1 (de)	2001-11-15
EP0546108A1 (en)	1993-06-16
DE69132805T2 (de)	2002-10-24
NZ239591A (en)	1994-07-26
AU649077B2 (en)	1994-05-12
DE69132805D1 (de)	2001-12-13
AU8725091A (en)	1992-03-30
PT98831B (pt)	1999-02-26
CA2088980A1 (en)	1992-03-01
NO930710L (no)	1993-04-21

Publication	Publication Date	Title
FI916060A0 (fi)	1991-12-20	Foerfarande foer framstaellning av n-substituerade cykloalkyl- och polycykloalkyl-a-substituerade trp-phe- och fenetylaminderivat.
DK0546108T3 (da)	2002-02-18	Pro-drugs for CCK-antagonister
KR100929363B1 (ko)	2009-12-02	벤질리덴아미노구아니딘 및 히드록시구아니딘의멜라노코르틴 수용체 리간드로서의 용도
DK0975595T3 (da)	2009-10-19	Kokainanaloger
MY123642A (en)	2006-05-31	Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, and processes for preparing them.
CA2417897A1 (en)	2003-01-30	Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
RU2005134230A (ru)	2006-05-10	Ацилированные производные спиропиперидина как агонисты рецептора меланокортина-4
HUT74949A (en)	1997-03-28	Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists
CN110272425A (zh)	2019-09-24	吡啶酰基八氢吡咯并[3,4-c]吡咯衍生物及其用途
WO2000055162A3 (en)	2000-12-28	Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
DE69810629T2 (de)	2003-10-16	Beta-alkoxyacrylate gegen malaria
EP0531228B1 (en)	1996-02-28	Thiourea derivatives, antimicrobial agent and antiulcer agent containing the same
ES2126577T3 (es)	1999-04-01	Analogos alquilidenicos de 1'-aminoespiro(isoquinolino-4(1h),3'-pirrolidino)-1,2',3,5'(2h)-tetronas utiles como inhibidores de la aldosa reductasa in vivo.
FR2647785B1 (fr)	1991-09-06	Nouveaux derives de la pyrrolidone, leur procede de preparation et les compositions pharmaceutiques les renfermant
RU93005013A (ru)	1996-05-10	1-аминоспиро[изохинолин-4(1н)3-пирролидин-1,2,3,5'(2н)-тетроны] и их аналоги, способ их получения и фармацевтическая композиция
ES531447A0 (es)	1984-12-16	Procedimiento de preparar derivados de n-cicloalcoilmetil-2 oxo-3 diaril 5-6 as triacina
WO1994022413A2 (en)	1994-10-13	Triazole substituted quinoline derivatives
NO930711L (no)	1993-04-26	Aminosyrederivater ringsluttet i den c-terminale ende
JP2001527076A (ja)	2001-12-25	海綿動物から単離されるアスマリンａ及びｂを含む細胞毒性アルカロイド誘導体
KR910000642A (ko)	1991-01-29	인돌 유도체 및 이의 제조방법

Legal Events

Date	Code	Title	Description
2005-05-02	MM1K	Lapsed by not paying the annual fees